title: Lipoprotein abnormalities in patients with asymptomatic acute porphyria.
abstract: There have been discrepancies in reports of total cholesterol and low density lipoprotein (LDL)-cholesterol levels in patients with acute porphyria. Some studies have found that acute porphyria patients have increased levels while others do not. The aim of this study has been to evaluate the lipid profile in a series of patients with acute porphyria, in order to help clarify these differences. Serum lipoprotein levels were studied in 30 patients (25 women and five men; age:38+/-10 years) with asymptomatic acute porphyria. Controls were 30 healthy volunteers matched for age and gender. For 13 patients and 15 controls, lipoprotein lipase and hepatic lipase activities were determined. Patients exhibited increased levels of total-cholesterol, LDL-cholesterol, high density lipoprotein (HDL)-cholesterol and apolipoprotein (apo)-A1 compared with controls (P4 mmol/l in 15 patients (50%). Levels of total triglycerides, very low density lipoprotein (VLDL)-triglycerides, VLDL-cholesterol, apo-B and lipoprotein(a) were similar in patients and controls. The hepatic lipase activity tended to be lower in patients than controls (33.8+/-17.7 vs. 50.4+/-23.0 pkat/ml; P=0.05). In conclusion, in patients with asymptomatic acute porphyria an increase of total and LDL-cholesterol was found. The cardiovascular risk conferred by this factor may be attenuated by increased HDL-cholesterol and apo-A1.
authors.affiliation: Servicio de Medicina Interna, Unidad de Lipidos, Hospital Universitario 12 de Octubre, 28041, Madrid, Spain. cfdezmirp@medynet.com
authors.forename: C
authors.initials: C
authors.lastname: Fernández-Miranda
authors.forename: M
authors.initials: M
authors.lastname: De La Calle
authors.forename: S
authors.initials: S
authors.lastname: Larumbe
authors.forename: T
authors.initials: T
authors.lastname: Gómez-Izquierdo
authors.forename: A
authors.initials: A
authors.lastname: Porres
authors.forename: J
authors.initials: J
authors.lastname: Gómez-Gerique
authors.forename: R
authors.initials: R
authors.lastname: Enríquez de Salamanca
mesh_terms: D000208:Acute Disease; D000328:Adult; D016632:Apolipoprotein A-I / Q000097:blood; D001055:Apolipoproteins B / Q000097:blood; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D005260:Female; D006801:Humans; D008049:Lipase / Q000097:blood; D008071:Lipoprotein Lipase / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000201:enzymology; D008297:Male; D011164:Porphyrias / Q000097:blood* / Q000145:classification / Q000652:urine; D011166:Porphyrins / Q000652:urine; D012016:Reference Values; D014280:Triglycerides / Q000097:blood
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D015243:Cholesterol, VLDL; D017270:Lipoprotein(a); D008074:Lipoproteins; D008079:Lipoproteins, VLDL; D011166:Porphyrins; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride; D002784:Cholesterol; D008049:Lipase; D008071:Lipoprotein Lipase